Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Molecular Biology
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Molecular Biology

[0597-PCR-VH024-48D] Borrelia burgdorferi PCR Test,48 Reactions
Borrelia burgdorferi PCR Test,48 Reactions
691.60 € 691.6 EUR
[0597-PCR-V228-96R] Bluetongue virus 8 - End-Point- 96 reactions
Bluetongue virus 8 - End-Point- 96 reactions
820.00 € 820.0 EUR
[0597-PCR-V610-48R] Bluetongue virus (Type 1-2-4-6-8-9-11-16) - PCR Test- 48 rxs
Bluetongue virus (Type 1-2-4-6-8-9-11-16) - PCR Test- 48 rxs
709.25 € 709.25 EUR
[0597-PCR-V224-48R] Bluetongue disease PCR - 48 rxs
Bluetongue disease PCR - 48 rxs
709.25 € 709.25 EUR
[0597-PCR-V224-96R] Bluetongue disease - End-Point- 96 reactions
Bluetongue disease - End-Point- 96 reactions
820.00 € 820.0 EUR
[0171-G891] BlasTaq 2X qPCR MasterMix - 500 rxn (4 x 1.25 ml)
BlasTaq 2X qPCR MasterMix - 500 rxn (4 x 1.25 ml)
361.28 € 361.28000000000003 EUR
[0356-P-1067-48] BisulPlus Loci 5mC & 5hmC Detection PCR Test - 2x 24 reactions
BisulPlus Loci 5mC & 5hmC Detection PCR Test - 2x 24 reactions
830.00 € 830.0 EUR
[0987-1808-1041] BioShake Adaptor – 96-well, V-bottomed, PCR Microplate
BioShake Adaptor – 96-well, V-bottomed, PCR Microplate
735.00 € 735.0 EUR
[0597-PCR-V332-96D] Batrachochytrium dendrobatidis PCR - 96 Reactions
Batrachochytrium dendrobatidis PCR - 96 Reactions
868.00 € 868.0 EUR
[0441-B74-FRT] Bacterial Vaginosis RT-PCR Quant (CE) – 100 Tests
Bacterial Vaginosis RT-PCR Quant (CE) – 100 Tests
1,074.00 € 1074.0 EUR
[0900-TBS42033-200] Bacillus cereus qPCR Test - 200 Reactions
Bacillus cereus qPCR Test - 200 Reactions
990.00 € 990.0 EUR
[0900-TBS42033-100] Bacillus cereus qPCR Test - 100 Reactions
Bacillus cereus qPCR Test - 100 Reactions
582.00 € 582.0 EUR
[0900-TBS42034-100] Bacillus Species Detection Taqman qPCR - 100 Tests
Bacillus Species Detection Taqman qPCR - 100 Tests
557.00 € 557.0 EUR
[0597-Oneq-V143-50D] Babesia equi One-Step PCR - 50 Reactions
Babesia equi One-Step PCR - 50 Reactions
774.80 € 774.8000000000001 EUR
[0597-Oneq-V143-150D] Babesia equi One-Step PCR - 150 Reactions
Babesia equi One-Step PCR - 150 Reactions
1,062.10 € 1062.1 EUR
[0597-Oneq-V143-100D] Babesia equi One-Step PCR - 100 Reactions
Babesia equi One-Step PCR - 100 Reactions
938.60 € 938.6 EUR
[0597-Oneq-V142-50D] Babesia caballi, One Step qPCR, 50rxn
Babesia caballi, One Step qPCR, 50rxn
938.60 € 938.6 EUR
[0597-PCR-V180-48D] Babesia bigemina PCR Test - 48 rxs
Babesia bigemina PCR Test - 48 rxs
441.50 € 441.5 EUR
[0597-Oneq-V180-50D] Babesia bigemina One Step PCR Test - 50 reactions
Babesia bigemina One Step PCR Test - 50 reactions
1,020.00 € 1020.0 EUR
[0597-PCR-V049-48R] Avian leukosis virus Rous sarcoma virus detection Tests -
Avian leukosis virus Rous sarcoma virus detection Tests -
1,127.50 € 1127.5 EUR
  • 1
  • 2
  • 3
  • 4
  • 5

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)